E Fund Management’s Bio-Techne TECH Stock Holding History

E Fund Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$445K	Sell	6,292 -141	-2%	-$7.61K	0.01%	302
2026 Q1	$336K	Buy	+6,433	New	+$386K	0.01%	365
2025 Q2	$283K	Buy	5,497 +235	+4%	+$11.8K	0.01%	317
2025 Q1	$309K	Buy	5,262 +621	+13%	+$42.1K	0.01%	307
2024 Q4	$334K	Buy	4,641 +2,013	+77%	+$148K	0.02%	297
2024 Q3	$210K	Buy	+2,628	New	+$197K	0.01%	323

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

E Fund Management's TECH Position: Q2 2026 in Review

E Fund Management reduced its Bio-Techne (TECH) stake by 2.2% in Q2 2026, selling an estimated $7.61K and leaving 6,292 shares worth $445K. The position accounts for 0.01% of the portfolio, ranked #302.

E Fund Management first reported a position in TECH in Q3 2024 and has held it in 6 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

E Fund Management held 6,292 shares of Bio-Techne worth $445K as of Q2 2026.
E Fund Management sold 141 Bio-Techne shares in Q2 2026, an estimated $7.61K.
Bio-Techne made up 0.01% of E Fund Management's portfolio in Q2 2026, its #302 holding.
E Fund Management first reported a position in Bio-Techne in Q3 2024 and has held it in 6 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.